| Original language | English |
|---|---|
| Pages (from-to) | 32S |
| Journal | Chest |
| Volume | 121 |
| Issue number | 3 |
| DOIs | |
| State | Published - 2002 |
Bibliographical note
Funding Information:Supported by Veterans Administration Career Development Award project No. 596–416905007–0001, and from a generous donation from the McDowell Foundation-Papa Johns/Valvano fund for cancer research.
Copyright:
Copyright 2021 Elsevier B.V., All rights reserved.
Funding
Supported by Veterans Administration Career Development Award project No. 596–416905007–0001, and from a generous donation from the McDowell Foundation-Papa Johns/Valvano fund for cancer research.
| Funders | Funder number |
|---|---|
| U.S. Department of Veterans Affairs | 596–416905007–0001 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Adenovirus
- Cyclo-oxygenase-2
- Gene therapy
- Non-small cell lung cancer
ASJC Scopus subject areas
- Pulmonary and Respiratory Medicine
- Critical Care and Intensive Care Medicine
- Cardiology and Cardiovascular Medicine
Fingerprint
Dive into the research topics of 'Induction of cyclo-oxygenase-2 in non-small cell lung cancer cells by adenovirus vector infection'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver